Yuki Gosei Kogyo Co.,Ltd. [4531.T]
TOKYO, May 19 (Pulse News Wire) – Yuki Gosei Kogyo CO.,LTD. (4531.T) unveiled its three-year mid-term business plan covering fiscal years 2026 through 2028.
The plan aims to achieve sustained growth despite ongoing geopolitical risks, particularly from the Middle East. Sales targets are set at ¥16 billion for FY2027 and ¥16.5 billion for FY2028. Operating profit margin remains undetermined due to unpredictable Middle Eastern conditions but will be disclosed once calculated accurately. Key strategies include enhancing product competitiveness, fostering innovation, and strengthening global supply chains.
Additionally, the company plans to expand its CDMO business in pharmaceuticals and invest in sustainable technologies. In terms of environmental, social, and governance (ESG) goals, Yuki Gosei Kogyo aims to reduce CO2 emissions by 50% compared to 2006 levels by 2030. It also seeks to maintain male paternity leave uptake rates at 100%. Risk management will be enhanced to ensure sustainable growth amid volatile business environments.
This plan reflects the company's commitment to long-term value creation and sustainability while addressing challenges posed by geopolitical uncertainties.
🟢 Confidence: High AI-translated content.